Dr Natalie Staplin
|Tel||+44 (0)1865 743975|
Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences. She joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics. Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease. She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
Mafham MM. et al, (2017), Nephrol Dial Transplant
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).
Staplin N. et al, (2016), Am J Kidney Dis, 68, 371 - 380
The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review.
Morton RL. et al, (2016), Nephrol Dial Transplant, 31, 46 - 56
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.
Morton RL. et al, (2016), Am J Kidney Dis, 67, 31 - 39
Dependent censoring in piecewise exponential survival models.
Staplin ND. et al, (2015), Stat Methods Med Res, 24, 325 - 341